Medline Industries, Inc. (NASDAQ: MDLN)

This investigation is for anyone who acquired securities in Medline Industries, Inc. (NASDAQ: MDLN) prior to June 2, 2026.

The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors by telling investors that the Company had controls in place to safely manufacture product when the Company lacked such controls.

On June 2, 2026, the FDA published a warning letter addressed to Medline regarding “significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals,” stating that, among other things, Medline “failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications.” On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Medline Industries, Inc. (NASDAQ: MDLN) prior to June 2, 2026 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.